The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC–MS

Bocci, 2000, Clin. Cancer Res., 6, 3032

Grem, 2000, Invest. New Drugs, 18, 299, 10.1023/A:1006416410198

Bading, 2003, Cancer Res., 63, 3667

Diasio, 1989, Clin. Pharmacokinet., 16, 215, 10.2165/00003088-198916040-00002

Tsume, 2008, Mol. Pharmacol., 5, 717, 10.1021/mp800008c

Weckbecker, 1991, Pharmacol. Ther., 50, 367, 10.1016/0163-7258(91)90051-M

Parker, 1990, Pharmacol. Ther., 48, 381, 10.1016/0163-7258(90)90056-8

van Laar, 1998, Eur. J. Cancer, 34, 296, 10.1016/S0959-8049(97)00366-3

Willmore, 1993, Biochem. Pharmacol., 46, 205, 10.1016/0006-2952(93)90405-L

Laskin, 1979, Cancer Res., 39, 383

Yamada, 1998, J. Neurooncol., 37, 115, 10.1023/A:1005869226496

Buzaid, 1989, Cancer Chemother. Pharmacol., 25, 124, 10.1007/BF00692352

Matsusaka, 2007, Chemotherapy, 53, 36, 10.1159/000098249

Carli, 2009, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 877, 2937, 10.1016/j.jchromb.2009.07.004

Del Nozal, 1994, J. Chromatogr. B: Biomed. Appl., 656, 397, 10.1016/0378-4347(94)00126-X

Licea-Perez, 2009, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 877, 1040, 10.1016/j.jchromb.2009.02.025

Remaud, 2005, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 824, 153, 10.1016/j.jchromb.2005.07.023

Xu, 2003, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 783, 273, 10.1016/S1570-0232(02)00674-8

Sommadossi, 1982, J. Biol. Chem., 257, 8171, 10.1016/S0021-9258(18)34313-8

Tsume, 2008, Molecules, 13, 1441, 10.3390/molecules13071441

Gupta, 2009, Mol. Pharmacol., 6, 1604, 10.1021/mp900084v

Landowski, 2005, Pharm. Res., 22, 1510, 10.1007/s11095-005-6156-9

Landowski, 2006, J. Pharmacol. Exp. Ther., 316, 572, 10.1124/jpet.105.092726

Landowski, 2005, Mol. Cancer Ther., 4, 659, 10.1158/1535-7163.MCT-04-0290

Malet-Martino, 1986, Cancer Res., 46, 2105

Miwa, 1998, Eur. J. Cancer, 34, 1274, 10.1016/S0959-8049(98)00058-6

Reigner, 2001, Clin. Pharmacokinet., 40, 85, 10.2165/00003088-200140020-00002

Coustere, 1991, Cancer Chemother. Pharmacol., 28, 123, 10.1007/BF00689701

Heggie, 1987, Cancer Res., 47, 2203

Fischel, 2004, Anticancer Drugs, 15, 969, 10.1097/00001813-200411000-00006

Hills, 1977, J. Pharm. Sci., 66, 1497, 10.1002/jps.2600661043

Marunaka, 1980, J. Pharm. Sci., 69, 1296, 10.1002/jps.2600691117

Jian, 2010, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 878, 3267, 10.1016/j.jchromb.2010.10.008

Chen, 2010, Bioanalysis, 2, 2011, 10.4155/bio.10.152

Montange, 2010, J. Mass Spectrom., 45, 670, 10.1002/jms.1759

Pisano, 2005, J. Pharm. Biomed. Anal., 38, 738, 10.1016/j.jpba.2005.01.039